Biotech · Private company
Molecular Insight Pharmaceuticals, Inc.
Track this companyFree. Adds Molecular Insight Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- 99mTc-MIP-1404 InjectionPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Whole-Body Planar and pelvic SPECT/CT scanPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Ultratrace® Iobenguane I131Phase 2 · PheochromocytomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate CancerPHASE3 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02615067 · fetched Nov 12, 2026
- A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/ParagangliomaPHASE2 · UNKNOWN · started Jun 4, 2009ClinicalTrials.gov NCT00874614 · fetched Nov 12, 2026
- Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/ParagangliomaAPPROVED_FOR_MARKETINGClinicalTrials.gov NCT02961491 · fetched Nov 12, 2026